Health Insurance Innovations (HIIQ) Stock Rating Lowered by ValuEngine

ValuEngine lowered shares of Health Insurance Innovations (NASDAQ:HIIQ) from a buy rating to a hold rating in a report issued on Wednesday.

A number of other equities analysts have also issued reports on HIIQ. BidaskClub raised shares of Health Insurance Innovations from a hold rating to a buy rating in a research report on Wednesday, February 28th. UBS Group raised shares of Health Insurance Innovations from a neutral rating to an outperform rating and set a $38.00 price target for the company in a research report on Thursday, March 1st. Cantor Fitzgerald reissued an overweight rating and set a $60.00 price target on shares of Health Insurance Innovations in a research report on Thursday, March 1st. Raymond James raised shares of Health Insurance Innovations from a market perform rating to an outperform rating and set a $34.60 price target for the company in a research report on Thursday, March 1st. Finally, Craig Hallum reissued a buy rating and set a $45.00 price target (up from $38.00) on shares of Health Insurance Innovations in a research report on Thursday, March 1st. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of Buy and an average price target of $42.62.

Health Insurance Innovations opened at $32.35 on Wednesday, according to MarketBeat Ratings. Health Insurance Innovations has a 12-month low of $12.65 and a 12-month high of $37.38. The company has a market cap of $537.87 million, a price-to-earnings ratio of 26.96 and a beta of 0.55.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its quarterly earnings results on Wednesday, May 2nd. The financial services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. Health Insurance Innovations had a net margin of 6.17% and a return on equity of 20.15%. The company had revenue of $67.80 million during the quarter, compared to analyst estimates of $68.53 million. During the same period last year, the firm posted $0.36 EPS. Health Insurance Innovations’s revenue for the quarter was up 21.3% compared to the same quarter last year. equities analysts predict that Health Insurance Innovations will post 2.09 earnings per share for the current fiscal year.

In other news, Director Anthony Barkett bought 3,597 shares of the business’s stock in a transaction dated Tuesday, May 8th. The stock was purchased at an average cost of $27.65 per share, with a total value of $99,457.05. Following the acquisition, the director now directly owns 52,944 shares in the company, valued at $1,463,901.60. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director John Fichthorn sold 18,414 shares of Health Insurance Innovations stock in a transaction that occurred on Friday, June 15th. The shares were sold at an average price of $34.98, for a total transaction of $644,121.72. Following the transaction, the director now directly owns 7,608 shares of the company’s stock, valued at $266,127.84. The disclosure for this sale can be found here. Over the last ninety days, insiders have bought 19,759 shares of company stock valued at $611,607. Insiders own 55.94% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Catalyst Capital Advisors LLC purchased a new position in shares of Health Insurance Innovations during the 1st quarter valued at approximately $578,000. Harvest Capital Strategies LLC increased its holdings in shares of Health Insurance Innovations by 9.0% during the 1st quarter. Harvest Capital Strategies LLC now owns 350,000 shares of the financial services provider’s stock valued at $10,115,000 after purchasing an additional 28,850 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. purchased a new position in shares of Health Insurance Innovations during the 1st quarter valued at approximately $143,000. Jane Street Group LLC increased its holdings in shares of Health Insurance Innovations by 58.0% during the 1st quarter. Jane Street Group LLC now owns 14,202 shares of the financial services provider’s stock valued at $410,000 after purchasing an additional 5,211 shares in the last quarter. Finally, Hancock Holding Co. acquired a new stake in Health Insurance Innovations in the 1st quarter valued at $305,000. 76.27% of the stock is owned by hedge funds and other institutional investors.

About Health Insurance Innovations

Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply